Загрузка...

Advancing Novel PrEP Products – Alternatives to Non-Inferiority

With the scale-up of HIV pre-exposure prophylaxis (PrEP) with tenofovir (TDF) with or without emtricitabine (FTC), we have entered an era of highly effective HIV prevention with a growing pipeline of potential products to be studied. These studies are likely to be randomized trials with an oral TDF/...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Stat Commun Infect Dis
Главный автор: Glidden, David V
Формат: Artigo
Язык:Inglês
Опубликовано: 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731035/
https://ncbi.nlm.nih.gov/pubmed/31497242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/scid-2019-0011
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!